How Did a $792 Hourly Rate for Autism Services Make It Through?

When $792 an hour gets paid for routine autism therapy services — nearly nine times the national average in-network rate — the natural reaction is outrage at the provider billing it.

But there's a more important question buried in that number.

How did that claim make it through the system?

Not as a rhetorical question. As an operational one. Because the answer tells you everything about where this industry is headed — and what it means for every legitimate provider and platform operating in this space right now.

Controls Failed To Keep Pace With Growth

The claims made it through because the controls were absent, inconsistently applied, or simply not mature enough to catch them early.

Not because the technology doesn't exist. Not because fraud detection is uniquely hard in autism care. The tools that catch these patterns are standard across mature healthcare markets.

Claims analytics that compare providers against peer groups. Utilization flags for billing volumes that exceed what's humanly possible. Provider credentialing verification. Post-payment audits that check whether documented services actually occurred. Electronic Visit Verification that confirms a clinician was where they said they were.

None of that is exotic. It exists in home health, pharmacy, durable medical equipment, and most other Medicaid-funded service categories that went through rapid growth phases before autism care did.

Autism care was simply never required to build those controls at the same pace the industry grew. Diagnoses expanded. Coverage mandates followed. New providers entered the market. Investment poured in. Access improved dramatically for thousands of families who needed it.

And the governance infrastructure lagged behind all of it.

That lag is what created the opening. Not uniquely corrupt providers. Not a uniquely vulnerable population. A controls gap that widened as the industry scaled, and that bad actors — who exist in every healthcare market — were willing to exploit.

Controls were not the only issue.

Some reimbursement methodologies amplified the problem. One of the more striking examples in the recent Wall Street Journal story The Autism-Therapy Business Is Booming—and So Is the Billing Abuse involved reimbursement structures that effectively tied payments to provider charges. In practical terms, higher charges produced higher reimbursement.

That is not primarily a fraud problem. It is a governance problem.

When reimbursement systems reward behavior policymakers never intended, organizations predictably optimize around the rules that exist. Effective governance requires both controls that identify outliers and reimbursement structures that discourage them in the first place.

The Measurement Problem Underneath The Controls Problem

There's another reason autism care didn't develop the same governance infrastructure that matured in other healthcare markets. And it's not simply that the industry grew too fast or that oversight was underfunded.

It's that nobody fully agrees on what appropriate care actually looks like.

In most healthcare markets where fraud, waste, and abuse controls work well, there's a clinical baseline to build from. A knee replacement has an expected recovery protocol. A home health episode has defined visit frequencies. A pharmacy claim can be validated against a diagnosis and prescribing patterns. The benchmarks that power claims analytics, utilization flags, and peer comparison tools are built on top of clinical consensus about what normal looks like.

Autism care doesn't have that foundation in the same way.

Every child sits at a different point on the spectrum. Goals vary dramatically. Treatment intensity varies dramatically. Progress is often nonlinear. Researchers, clinicians, providers, and payors continue to debate what appropriate utilization looks like for many children.

That ambiguity matters because most oversight systems depend on benchmarks. And benchmarks require some degree of consensus.

You cannot build a meaningful peer comparison model without a defensible definition of typical. You cannot confidently identify utilization outliers when the clinical community itself continues to debate what appropriate intensity looks like. You cannot easily distinguish aggressive treatment from excessive treatment when outcome frameworks remain immature.

This is not an excuse for the billing patterns documented in recent litigation and federal audits. Providers billing for more hours of service than exist in a day, or submitting claims at multiples of any defensible market rate, don't require clinical nuance to identify as problematic.

Those cases are straightforward.

But they sit at the far end of a much broader continuum where the boundaries are considerably less clear. That complexity is a significant part of why the governance infrastructure never fully matured.

Why Legitimate Providers Should Pay Attention

The correction is already underway.

Prior authorization requirements are tightening. Claims reviews are increasing. Provider enrollment standards are becoming more restrictive. States are revisiting reimbursement methodologies. Federal auditors are expanding their reviews.

For legitimate providers, this often feels frustrating because broad oversight mechanisms affect everyone before regulators have enough information to distinguish good actors from bad ones with confidence.

That is not primarily a punitive response. It is a data problem.

When payors and regulators lack the infrastructure necessary to distinguish a provider billing 200 hours a month legitimately from one billing 200 hours fraudulently, they tend to treat both the same way.

The organizations most likely to navigate this period successfully are the ones that can demonstrate the integrity of their operations clearly and quickly: clean documentation, defensible utilization patterns, reliable audit trails, and outcome data that supports treatment intensity.

Increasingly, those capabilities are becoming strategic assets rather than compliance functions.

Where Platforms Fit

The longer-term solution is not simply more audits.

It is better visibility into what is actually happening.

Better outcome measurement. Better claims analytics. Better verification. Better governance.

Much of that work sits beyond the reach of individual providers. Outcome frameworks require collaboration between payors, Medicaid agencies, researchers, and professional associations. No individual clinic can solve that problem on its own.

Platforms, however, occupy a different position.

They are not price takers in the way providers often are. They have the technical capability to deploy EVV before regulators require it. They can build anomaly detection into workflows before payors demand it. They can instrument their networks to generate utilization benchmarks and operational visibility that regulators currently lack.

The most ambitious platforms can go even further.

They can build the claims analytics, utilization benchmarking, outcome tracking, and governance tools that both providers and payors increasingly need. In doing so, they create value not only for their customers but for the broader ecosystem that depends on better visibility.

The governance infrastructure that should have been built alongside this industry's growth still needs to be built.

That is not simply a challenge. For the right platforms, it is a product opportunity.

The Question Worth Asking

The autism industry spent much of the last decade focused on expanding access to care.

That work mattered. The next phase will be different.

The challenge now is not simply expanding access. It is building the infrastructure required to govern that access responsibly.

The most important question raised by the recent headlines is not whether fraud exists.

Of course it does.

The more important question is whether autism care is finally developing the ability to distinguish abuse, administrative failure, and legitimate care before they all become the same headline.

The claims that made it through the system before are becoming harder to get through now.

Providers can control how prepared they are for that reality.

Platforms can help determine how quickly the system becomes sophisticated enough to tell the difference.